Sunesis to Present at Upcoming Investor Conferences
Leerink Global Healthcare Conference Thursday, February 13th at 11:10 AM Eastern Time
Astoria, New YorkCity
RBC Capital Markets'Global Healthcare Conference Tuesday, February 25th at 1:35 PM Eastern Time The New York Palace Hotel, New York City
A live webcast of the presentations will be available on the Sunesis website at http://ir.sunesis.com. A replay of the webcast will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks.
Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, vosaroxin, in multiple indications to improve the lives of people with cancer.
For additional information on Sunesis, please visit http://www.sunesis.com.
CONTACT: Investor and Media Inquiries:
David Pitts Argot Partners212-600-1902 Eric Bjerkholt Sunesis Pharmaceuticals Inc.650-266-3717 Eliza Schleifstein Argot Partners917-763-8106 firstname.lastname@example.org